Published Studies Related to Milrinone in Dextrose
Well-designed clinical trials related to Milrinone in Dextrose
Low central venous pressure with milrinone during living donor hepatectomy. [2010.04]
Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial. [2010]
Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. [2009.02]
Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. [2008.10.14]
Randomized Trial of Milrinone Versus Placebo for Prevention of Low Systemic Blood Flow in Very Preterm Infants. [2008.09.24]
Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan-type procedure: a prospective, randomized study. [2008.09]
[Efficacy of continuous intraoperative administration of low-dose milrinone during the circumflex artery anastomosis of off-pump coronary artery bypass] [2007.06]
Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. [2007.03]
The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. [2007]
The effect of milrinone on the right ventricular function in patients with reduced right ventricular function undergoing off-pump coronary artery bypass graft surgery. [2006.10]
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. [2006.06]
Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. [2006.04]
Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. [2006]
Hemodynamic changes during off-pump coronary artery bypass anastomosis in patients with coexisting mitral regurgitation: improvement with milrinone. [2005.07]
Effects of milrinone versus epinephrine on left ventricular relaxation after cardiopulmonary bypass following myocardial revascularization: assessment by color m-mode and tissue Doppler. [2005.06]
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. [2005.05.17]
Well-designed clinical trials possibly related to Milrinone in Dextrose
Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients. [2009.12]
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. [2008.01]
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. [2007.11.01]
Sildenafil for pulmonary hypertension in neonates. [2007.07.18]
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. [2007.06]
The effects of levosimendan in cardiac surgery patients with poor left ventricular function. [2007.04]
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. [2006.08]
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. [2006.04]
Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. [2006]
Overview of randomized clinical trials in acute heart failure syndromes. [2005.09.19]
Other research related to Milrinone in Dextrose
Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. [2012]
Milrinone, a phosphodiesterase III inhibitor, prevents reduction of jugular bulb
saturation during rewarming from hypothermic cardiopulmonary bypass. [2012]
Milrinone, a phosphodiesterase III inhibitor, prevents reduction of jugular bulb saturation during rewarming from hypothermic cardiopulmonary bypass. [2011.10.04]
Milrinone and Mortality in Adult Cardiac Surgery: A Meta-analysis. [2011.09.21]
Effect of milrinone on ischemia-reperfusion injury in the rat kidney. [2011.06]
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. [2011.06]
The role of milrinone in children with cardiovascular compromise: review of the literature. [2011.04]
The effect of milrinone on the intraoperative hemodynamics during off-pump coronary bypass surgery in patients with an elevated echocardiographic index of the ventricular filling pressure. [2011.03]
Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. [2011.02]
Use of milrinone in the management of haemodynamic instability following duct ligation. [2011.01]
Milrinone for persistent pulmonary hypertension of the newborn. [2010.11.10]
Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. [2010.10]
Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. [2010.09]
Combined usage of inhaled and intravenous milrinone in pulmonary hypertension after heart valve surgery. [2010.09]
The effect of milrinone infusion on right ventricular function during coronary anastomosis and early outcomes in patients undergoing off-pump coronary artery bypass surgery. [2010.08]
Suppressing apoptosis with milrinone simulating extracorporeal circulation: a pilot study. [2010.08]
Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. [2010.07]
Efficacy of milrinone versus nitroglycerin in controlling pulmonary arterial hypertension induced by intravenous injections of absolute ethanol in anesthetized dogs. [2010.06]
Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen. [2010.06]
Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction. [2010.05]
Milrinone improves diastolic function in coronary artery bypass surgery as assessed by acoustic quantification and peak filling rate: a prospective randomized study. [2010.04]
Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. [2010.03.01]
Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide-treated with milrinone: a case report. [2010.01]
Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. [2010.01]
Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart
disease suffering from pulmonary artery hypertension. [2010]
Milrinone improves diastolic function in coronary artery bypass surgery as
assessed by acoustic quantification and peak filling rate: a prospective
randomized study. [2010]
Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone. [2009.11]
Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure. [2009.11]
The efficacy of intravenous milrinone in left ventricular restoration. [2009.08]
Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment. [2009.07]
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. [2009.07]
Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. [2009.04]
High performance liquid chromatography using UV detection for the quantification of milrinone in plasma: improved sensitivity for inhalation. [2009.03.01]
Intestinal hemodynamic effects of milrinone in asphyxiated newborn pigs after reoxygenation with 100% oxygen: a dose-response study. [2009.03]
Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study. [2009.02]
Milrinone infusion: a therapeutic option in coronary vasospasm after primary percutaneous transluminal coronary angioplasty. [2009.01]
Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. [2009.01]
Inhaled milrinone attenuates experimental acute lung injury. [2009.01]
Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. [2009.01]
Potential for pulmonary protection by nebulized milrinone during warm ischemia. [2008.12]
The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times. [2008.12]
Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after fontan procedure. [2008.11]
Milrinone Increases Flow in Coronary Artery Bypass Grafts After Cardiopulmonary Bypass: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. [2008.09.18]
Correlation between plasma milrinone concentration and renal function in patients with cardiac disease. [2008.08]
Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxia-reoxygenation. [2008.07]
INTESTINAL HEMODYNAMIC EFFECTS OF MILRINONE IN ASPHYXIATED NEWBORN PIGS AFTER REOXYGENATION WITH 100% OXYGEN: A DOSE-RESPONSE STUDY [MILRINONE INTESTINAL EFFECTS IN NEWBORN ASPHYXIA]. [2008.06.27]
Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure. [2008.04]
Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxia-reoxygenation. [2008.03.21]
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs. [2008.03]
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. [2008.03]
Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog. [2008.03]
The effect of milrinone on metabolism after cardiopulmonary bypass. [2008.02]
Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. [2008]
Nebulized milrinone use in a pulmonary hypertensive crisis. [2007.12]
Milrinone does not improve free flap survival in microvascular surgery. [2007.10]
Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. [2007.07]
Long-term support with milrinone prior to cardiac transplantation in a neonate with left ventricular noncompaction cardiomyopathy. [2007.07]
Preliminary experience with inhaled milrinone in cardiac surgery. [2007.06]
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. [2007.05]
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. [2007.05]
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. [2007.05]
The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. [2007.04.30]
Nesiritide compared with milrinone for cardiac surgery. [2007.03]
Effects of Low-dose Milrinone on Weaning from Cardiopulmonary Bypass and after in Patients with Mitral Stenosis and Pulmonary Hypertension. [2007.02]
Milrinone combined with vasopressin improves cardiac index after cardiopulmonary resuscitation in a pig model of myocardial infarction. [2007.01]
Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. [2007.01]
Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. [2007.01]
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. [2006.12.15]
Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. [2006.12]
Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. [2006.12]
Inhaled milrinone: a new alternative in cardiac surgery? [2006.12]
Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy. [2006.11]
Milrinone administered before ischemia or just after reperfusion, attenuates myocardial stunning in anesthetized swine. [2006.10]
Effects of milrinone on blood flow of the Y-graft composed with the radial and the internal thoracic artery in patients with coronary artery disease. [2006.08]
Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs. [2006.06]
|
